prednisone has been researched along with Conjunctival Diseases in 15 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Conjunctival Diseases: Diseases involving the CONJUNCTIVA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report the authors' experience with azathioprine and prednisone combination for adult periocular and orbital xanthogranulomatous disease." | 7.77 | Azathioprine and prednisone combination treatment for adult periocular and orbital xanthogranulomatous disease. ( Bijlsma, WR; Paridaens, D; van Daele, PL; van den Bosch, WA, 2011) |
| "To report the authors' experience with azathioprine and prednisone combination for adult periocular and orbital xanthogranulomatous disease." | 3.77 | Azathioprine and prednisone combination treatment for adult periocular and orbital xanthogranulomatous disease. ( Bijlsma, WR; Paridaens, D; van Daele, PL; van den Bosch, WA, 2011) |
| "Pain is historically considered a cardinal sign of acute inflammation and a predominant symptom of IOIS." | 2.46 | Idiopathic orbital inflammatory syndrome without pain: a case report. ( Boothe, KH; Eckermann, DR; Musick, AN; Slagle, AM; Slagle, WS, 2010) |
| " EBV-related polymorphic PTLD was diagnosed and treated with discontinuation of cyclosporine, reduction in prednisone dosage and administration of EBV-specific cytotoxic T lymphocytes." | 1.34 | Conjunctival posttransplantation lymphoproliferative disorder. ( Irshad, FA; Onciu, MM; Walton, RC; Wilson, TD, 2007) |
| "A patient with a conjunctival blister was diagnosed with pemphigus vulgaris by immunofluorescence tests performed on a conjunctival biopsy." | 1.33 | [Conjunctival blistering associated with pemphigus vulgaris: report of a case]. ( Alvarez, MA; Bianciotto, C; Herreras Cantalapiedra, JM; Méndez Díaz, MC, 2005) |
| "Human cysticercosis is secondary to an infestation by cysticercus cellulosae, the larval form of Taenia solium." | 1.30 | Orbital cysticercosis. ( Lemke, BN; Sekhar, GC, 1997) |
| "Microscopic polyangiitis is an exclusively small-vessel (arterioles, capillaries, or venules) vasculitis that primarily involves the kidney and often involves the lungs, skin, or nervous system." | 1.29 | Microscopic polyangiitis with ocular involvement. ( Caster, JC; Pappolla, MA; Shetlar, DJ; Yee, RW, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D | 1 |
| Min, HY | 1 |
| Jankauskiene, A | 1 |
| Buteikiene, I | 1 |
| Thorne, JE | 2 |
| Woreta, FA | 1 |
| Jabs, DA | 3 |
| Anhalt, GJ | 1 |
| Bijlsma, WR | 1 |
| van den Bosch, WA | 1 |
| van Daele, PL | 1 |
| Paridaens, D | 1 |
| Slagle, WS | 1 |
| Boothe, KH | 1 |
| Musick, AN | 1 |
| Eckermann, DR | 1 |
| Slagle, AM | 1 |
| Paulus, YM | 1 |
| Cockerham, KP | 1 |
| Cockerham, GC | 1 |
| Gratzinger, D | 1 |
| Mokete, B | 1 |
| Thompson, GM | 1 |
| Bianciotto, C | 1 |
| Herreras Cantalapiedra, JM | 1 |
| Alvarez, MA | 1 |
| Méndez Díaz, MC | 1 |
| Qazi, FA | 1 |
| Nguyen, QD | 1 |
| Kempen, JH | 1 |
| Dunn, JP | 1 |
| Ah-Chan, JJ | 1 |
| Molteno, AC | 1 |
| Bevin, TH | 1 |
| Walton, RC | 1 |
| Onciu, MM | 1 |
| Irshad, FA | 1 |
| Wilson, TD | 1 |
| Foster, CS | 1 |
| Wilson, LA | 1 |
| Ekins, MB | 1 |
| Caster, JC | 1 |
| Shetlar, DJ | 1 |
| Pappolla, MA | 1 |
| Yee, RW | 1 |
| Sekhar, GC | 1 |
| Lemke, BN | 1 |
| Farr, AK | 1 |
| Green, WR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Myfortic (Enteric-coated Mycophenolate Sodium) for the Treatment of Non-infectious Intermediate Uveitis - a Prospective, Controlled, Randomized Multicenter Trial[NCT01092533] | Phase 3 | 44 participants (Actual) | Interventional | 2010-03-31 | Completed | ||
| First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial[NCT01829295] | Phase 3 | 216 participants (Actual) | Interventional | 2013-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Controlled ocular inflammation (≤ 0.5+ anterior chamber cells, ≤ 0.5+ vitreous haze, no active retinal/choroidal lesions in both eyes) with 7.5 mg/day of oral prednisone and ≤ 2 drops/day of topical 1% prednisolone acetate for patients who crossed over to other medication following treatment failure at 6 months (or earlier). (NCT01829295)
Timeframe: 6 Months
| Intervention | Participants (Count of Participants) |
|---|---|
| Switched Over to Methotrexate | 20 |
| Switched Over to Mycophenolate Mofetil | 7 |
Controlled ocular inflammation (≤ 0.5+ anterior chamber cells, ≤ 0.5+ vitreous haze, no active retinal/choroidal lesions in both eyes) with 7.5 mg/day of oral prednisone and ≤ 2 drops/day of topical 1% prednisolone acetate in patients who were a treatment success at the primary outcome of 6 months. (NCT01829295)
Timeframe: 12 Months
| Intervention | Participants (Count of Participants) |
|---|---|
| Methotrexate | 48 |
| Mycophenolate Mofetil | 40 |
Controlled ocular inflammation (≤ 0.5+ anterior chamber cells, ≤ 0.5+ vitreous haze, no active retinal/choroidal lesions in both eyes) with 7.5 mg/day of oral prednisone and ≤ 2 drops/day of topical 1% prednisolone acetate. (NCT01829295)
Timeframe: 6 Months
| Intervention | Participants (Count of Participants) |
|---|---|
| Methotrexate | 64 |
| Mycophenolate Mofetil | 56 |
1 review available for prednisone and Conjunctival Diseases
| Article | Year |
|---|---|
Idiopathic orbital inflammatory syndrome without pain: a case report.
Topics: Aged; Conjunctival Diseases; Dacryocystitis; Diagnosis, Differential; Edema; Humans; Inflammation; M | 2010 |
14 other studies available for prednisone and Conjunctival Diseases
| Article | Year |
|---|---|
Conjunctival langerhans cell histiocytosis: a case report.
Topics: Conjunctival Diseases; Cyclophosphamide; Cyclosporine; Female; Histiocytosis, Langerhans-Cell; Human | 2015 |
Severe chemosis in a patient with nephrotic syndrome.
Topics: Adolescent; Albumins; Angiotensin-Converting Enzyme Inhibitors; Conjunctival Diseases; Cyclosporine; | 2009 |
Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Cyclophosphamide; Female; Humans; Immunosuppr | 2008 |
Azathioprine and prednisone combination treatment for adult periocular and orbital xanthogranulomatous disease.
Topics: Adult; Aged; Azathioprine; Conjunctival Diseases; Drug Therapy, Combination; Eye Diseases; Eyelid Di | 2011 |
IgG4-positive sclerosing orbital inflammation involving the conjunctiva: a case report.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Biopsy; C-Reactive Protein; | 2012 |
Giant fornix syndrome.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Blepharospasm; Botulinum Toxins, Type A; Conjunctiva | 2005 |
[Conjunctival blistering associated with pemphigus vulgaris: report of a case].
Topics: Aged; Autoantibodies; Autoimmune Diseases; Biopsy; Blister; Conjunctiva; Conjunctival Diseases; Fluo | 2005 |
Mycophenolate mofetil therapy for inflammatory eye disease.
Topics: Adolescent; Adult; Aged; Child; Conjunctival Diseases; Drug Therapy, Combination; Female; Glucocorti | 2005 |
Mycophenolate mofetil therapy for inflammatory eye disease.
Topics: Adolescent; Adult; Aged; Child; Conjunctival Diseases; Drug Therapy, Combination; Female; Glucocorti | 2005 |
Mycophenolate mofetil therapy for inflammatory eye disease.
Topics: Adolescent; Adult; Aged; Child; Conjunctival Diseases; Drug Therapy, Combination; Female; Glucocorti | 2005 |
Mycophenolate mofetil therapy for inflammatory eye disease.
Topics: Adolescent; Adult; Aged; Child; Conjunctival Diseases; Drug Therapy, Combination; Female; Glucocorti | 2005 |
Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure.
Topics: Aged; Anti-Inflammatory Agents; Chronic Disease; Colchicine; Conjunctiva; Conjunctival Diseases; Dic | 2006 |
Conjunctival posttransplantation lymphoproliferative disorder.
Topics: Biomarkers; Bone Marrow Transplantation; Child; Conjunctival Diseases; Cyclosporine; DNA, Viral; Eps | 2007 |
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid.
Topics: Adult; Aged; Azathioprine; Cicatrix; Conjunctival Diseases; Corneal Diseases; Cyclophosphamide; Drug | 1982 |
Microscopic polyangiitis with ocular involvement.
Topics: Adult; Anti-Inflammatory Agents; Conjunctiva; Conjunctival Diseases; Cyclophosphamide; Eyelid Diseas | 1996 |
Orbital cysticercosis.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Conjunctiva; Conjun | 1997 |
Optic disc sarcoid granuloma.
Topics: Adult; Conjunctival Diseases; Female; Glucocorticoids; Granuloma; Humans; Optic Disk; Optic Nerve Di | 2000 |